Jilin Jian Yisheng Pharmaceutical Co.,Ltd.



Quote for Jilin Jian Yisheng Pharmaceutical Co.,Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002566
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002566 quote

Summary for Jilin Jian Yisheng Pharmaceutical Co.,Ltd.

JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. is principally engaged in the research, development, production and distribution of Chinese patent drugs for the treatment of cardiovascular and cerebrovascular disease. The Company's main products consist of Shengmai injections, Zhenyuan capsules, Xinyue capsules, Qingkailing injections and Guifu Dihuang capsules, among others. The Company's products are applied not only in the treatment for heart cerebrovascular diseases, but also in respiratory system diseases, alimentary system diseases, endocrine system diseases, urinary system diseases, tumors and paediatric diseases, among others. The Company distributes its products within China market.

Profile for Jilin Jian Yisheng Pharmaceutical Co.,Ltd.

Full Name:Jilin Jian Yisheng Pharmaceutical Co.,Ltd.
Full Name in Chinese:吉林省集安益盛药业股份有限公司 Short Name in Chinese:益盛药业
Symbol/Stock Code:
002566
Listed in:
Shanghai Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Zhang Yisheng
Secretary of the Board:
Li Tiejun
Phone:
+86-435-6236009
Fax:
+86-435-6236009
Official Website:www.yisheng-pharm.com
E-mail:yisheng@yisheng-pharm.com
Address:No.17-20 Wenhua East Road,No.17-20 Wenhua East Road,134200,JI’AN JLN 134200
IPO Subscription Date:
2011-03-09
Listing Date:
2011-03-18
IPO Issued Capital:
27600000
IPO Price:
39.9 CNY
IPO fees:
62018800 CNY
Money Raised by IPO:
1101240000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
1039221200 CNY
Open(Listing day):
39.00 CNY
Close(Listing day):
40.04 CNY
Diluted P/E ratio after IPO:
52.5000
Turnover rate(listing day):
52.53%

Financials for Jilin Jian Yisheng Pharmaceutical Co.,Ltd.

UPDATE:2012-10-23 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
70.4295
96.4841
87.638
61.1288
Net Profit Growth(%)
10.00
10.09
43.36
47.77
Return On Equity(ROE)(%)
4.57
6.46
24.43
21.81
Debt ratio(%)
4.77
4.08
30.22
34.29
Net Operating Cash Flow/Net Profit(%)
52.07
-116.21
57.88
204.89

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.3200
0.9300
1.0600
0.7400
Diluted Earnings Per Share
0.0000
0.9200
1.0100
0.7200
Net Asset Value Per Share (NAVPS)
6.9900
13.5500
4.3400
4.5900
Additional Paid-In Capital Per Share
4.2607
9.5214
0.4685
0.6324
Retained Earnings Per Share
1.4788
2.5204
2.3078
2.3314
Net Cash Flow From Operatings Activities Per Share
0.1700
-1.0200
0.6100
2.0400
Net Cash Flow Per Share
-0.3327
7.5934
-0.0115
0.3886

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
1641.1646
1578.6302
515.0594
427.6648
Total Liabilities(Million)
78.4263
64.5171
155.661
146.6739
Current Liabilities(Million)
52.4478
46.7619
138.7159
131.0426
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
810.4725
883.8668
46.1807
47.1354
Accounts Receivables(Million)
190.5956
170.6714
87.7126
74.9852
Deposit Received(Million)
1.8771
0.259
2.2458
19.5483
Other Receivables(Million)
22.0761
22.5132
17.6226
18.5075
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
1542.4912
1494.2665
358.7248
280.2776
Debt ratio(%)
4.77
4.08
30.22
34.29
Equity Ratio(%)
93.9800
94.6500
69.6400
65.5300
Current Ratio
26.2562
28.8526
2.2560
1.9364
Quick Ratio
22.6006
25.9904
1.5457
1.4112

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
508.6401
471.7745
558.1856
507.2033
Net Cash Flow From Operatings Activities(Million)
36.6704
-112.1209
50.7253
125.2463
Net Cash Flow From Operatings Activities Change(%)
-141.80
-321.04
-59.50
511.03
Net Cash Flow(Million)
-73.3943
837.686
-0.9547
23.8086
Cash From Selling Commodities/Prime Revenue(%)
114.61
89.19
108.13
122.25
Net Cash Flow/Net Profit(%)
-104.21
868.21
-1.09
38.95
Cash Flow From Investing Activities(Million)
-86.0566
-44.0795
-56.8401
-42.4095
Cash Flow From Financing Activities(Million)
-24.0081
993.8865
5.1602
-59.0282

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
443.8025
528.9253
516.2241
414.8844
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
200.8631
224.6119
235.4454
191.8159
Administrative Costs(Million)
40.3787
69.6753
49.4344
43.042
Financing Costs(Million)
-18.4413
-21.0307
1.5478
2.09
Above Three Costs Change(%)
15.20
-4.60
20.88
29.73
Operating Profit(Million)
75.9338
107.2893
98.2116
67.0726
Income From Investment(Million)
-
-
0.0287
-0.0039
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
5.9817
5.6712
4.5952
1.4167
Total Profit(Million)
81.9155
112.9605
102.8068
68.4893
Corporate Income Tax(Million)
11.0855
16.1705
15.2084
7.386
Net Profit(Million)
70.4295
96.4841
87.638
61.1288
Gross Profit Ratio(%)
68.94
74.58
75.79
74.81
Operating Margin(%)
17.10
20.28
19.02
16.16
Return On Equity(ROE)(%)
4.57
6.46
24.43
21.81

Announcements for Jilin Jian Yisheng Pharmaceutical Co.,Ltd.

Date: 2012-04-11
Title: DIVIDEND IMPLEMENTATION (CASH AND BONUS ISSUE)
2011 final distribution plan to be implemented (A shares):

1. Cash dividend/10 shares (tax included): CNY2.00000000
2. Bonus issue from profit (share/10 shares): none
3. Bonus issue from capital reserve (share/10 shares): 10.0000


Record date: 17 April 2012
Ex-date: 18 April 2012
Payment date: 18 April 2012
Listing date of the bonus issues: 18 April 2012.
10 percent withholding tax on cash dividend will be deducted in CNY within the cash dividend receivable. Please refer to below details:
Tax on cash dividend/10 shares: CNY0.20000000(10 percent x CNY2.00000000)
Net cash dividend/10 shares after tax: CNY1.80000000(CNY2.00000000- CNY0.20000000)
Date: 2012-04-11
Title: BONUS ISSUE IMPLEMENTATION
2011 final distribution plan to be implemented (A shares):

1. Cash dividend/10 shares (tax included): CNY0.00000000
2. Bonus issue from profit (share/10 shares): none
3. Bonus issue from capital reserve (share/10 shares): 10.0000

Record date: 17 April 2012
Ex-date: 18 April 2012
Payment date: 18 April 2012
Listing date of the bonus issues: 18 April 2012.
Date: 2012-03-28
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 27 March 2012, during which the following proposal(s) was/were approved:
1. 2011 annual report and its summary
2. 2011 work report of the board of directors
3. 2011 work report of the supervisory committee
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. Special report on the deposit and use of raised funds in 2011
7. Re-appointment of 2012 audit firm
8. Amendments to the Company's articles of association
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY2.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): 10.00.
Date: 2012-03-15
Title: RESTRICTED SHARE LISTING
Among the Company's 39824676 restricted shares to be unlocked on 19 March 2012, 39824676 of them will be tradable on the Shenzhen Stock Exchange on that day.
Date: 2012-03-06
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 06 March 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY2.00000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):10.0000.
Date: 2012-03-06
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 09:00 on 27 March 2012.

Meeting agenda:
1. 2011 annual report and its summary
2. 2011 work report of the board of directors
3. 2011 work report of the supervisory committee
4. 2011 financial resolution report
5. 2011 profit distribution plan
6. Special report on the deposit and use of raised funds in 2011
7. Re-appointment of 2012 audit firm
8. Amendments to the Company's articles of association
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY2.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): 10.0000

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 22 March 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 26 March 2012
Date: 2011-08-03
Title: EGM-SPOT
The Company will hold the 1ST EGM OF 2011 at 09:00 on 19 August 2011.

Meeting agenda:
1. Investment in construction of a project with partial over-raised funds
2. Investment in construction of another project with partial over-raised funds
3. Amendments to the management measures on the use of raised funds
4. Amendments to the external investment management system
5. Election of Mr Xiao Bohua as supervisor

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 12 August 2011 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 17 August 2011
Date: 2011-06-15
Title: PLACING SHARE LISTING
THE CO'S 5.52 MILLION A-SHARES PLACED TO THE INSTITUTIONAL INVESTORS THROUGH OFFLINE PLACEMENT WILL REACH THE 3-MONTH LOCK-UP PERIOD AND BE LISTED ON THE SHENZHEN STOCK EXCHANGE AS OF 20JUN11.
Date: 2011-03-17
Title: IPO SHARE LISTING
THE CO ISSUED A TOTAL OF 27.6 MILLION SHARES (CODE:002566) IN ITS INITIAL PUBLIC OFFERING. OF THE SHARES,22.08 MILLION SHARES WILL BE LISTED ON THE SHENZHEN STOCK EXCHANGE ON 18MAR11 WHILE THE REMAINDER WILL BECOME TRADABLE THREE MONTHS LATER.
Date: 2011-03-08
Title: IPO-ONLINE SUBSCRIPTION
JILIN JIAN YISHENG PHARMACEUTICAL CO., LTD. HAS BEEN APPROVED BY THE CHINA SECURITIES REGULATORY COMMISSION (THE CSRC) TO ISSUE 27.600000 MILLION A-SHARES IN ITS INITIAL PUBLIC OFFERING.
1. CLASS: A SHARES
2. STOCK CODE: 002566
3. STOCK ABBREVIATION: YISHENG PHARMACEUTICAL
4. ISSUING VOLUME: 27.600000 MILLION SHARES
5. PAR VALUE: CNY1.00 PER SHARE
6. ISSUING MECHANISM: A BOOK BUILDING PROCESS WILL BE CONDUCTED WITH A COMBINATION OF ONLINE PUBLIC OFFERING AND OFFLINE PLACEMENT.
7. TARGETED LISTING BOURSE: SHENZHEN STOCK EXCHANGE
8. OFFLINE PLACEMENT VOLUME:5.520000 MILLION SHARES
9. ONLINE OFFERING VOLUME: 22.080000 MILLION SHARES
10. PRICE: CNY39.90 PER SHARE
11. OFFLINE SUBSCRIPTION PERIOD:09MAR11
12. ONLINE SUBSCRIPTION DATE: 09MAR11